13 research outputs found
Low-basicity 5-HT7 receptor agonists synthesized using the van Leusen multicomponent protocol
A series of 5-aryl-1-alkylimidazole derivatives was synthesized using the van Leusen multicomponent
reaction. The chemotype is the first example of low-basicity scaffolds exhibiting high affinity for 5-HT7
receptor together with agonist function. The chosen lead compounds 3-(1-ethyl-1H-imidazol-5-yl)-5-
iodo-1H-indole (AGH-107, 1o, Ki 5-HT7=6nM, EC50=19nM, 176-fold selectivity over 5-HT1AR) and 1e
(5-methoxy analogue, Ki 5-HT7=30nM, EC50=60nM) exhibited high selectivity over related CNS targets,
high metabolic stability and low toxicity in HEK-293 and HepG2 cell cultures. A rapid absorption to the
blood, high blood-brain barrier permeation and a very high peak concentration in the brain (Cmax=2723
ng/g) were found for 1o after i.p. (5mg/kg) administration in mice. The compound was found active
in novel object recognition test in mice, at 0.5, 1 and 5mg/kg. Docking to 5-HT7R homology models
indicated a plausible binding mode which explain the unusually high selectivity over the related CNS
targets. Halogen bond formation between the most potent derivatives and the receptor is consistent
with both the docking results and SAR. 5-Chlorine, bromine and iodine substitution resulted in a 13, 27
and 89-fold increase in binding affinities, respectively, and in enhanced 5-HT1AR selectivity
Design and synthesis of new quinazolin-4-one derivatives with negative receptor modulation activity and antipsychotic-like properties
Following the glutamatergic theory of schizophrenia and based on our previous study regarding the antipsychotic-like activity of mGlu7 NAMs, we synthesized a new compound library containing 103 members, which were examined for NAM mGlu7 activity in the T-REx 293 cell line expressing a recombinant human mGlu7 receptor. Out of the twenty-two scaffolds examined, active compounds were found only within the quinazolinone chemotype. 2-(2-Chlorophenyl)-6-(2,3-dimethoxyphenyl)-3-methylquinazolin-4(3H)-one (A9-7, ALX-171, mGlu7 IC50 = 6.14 µM) was selective over other group III mGlu receptors (mGlu4 and mGlu8), exhibited satisfactory drug-like properties in preliminary DMPK profiling, and was further tested in animal models of antipsychotic-like activity, assessing the positive, negative, and cognitive symptoms. ALX-171 reversed DOI-induced head twitches and MK-801-induced disruptions of social interactions or cognition in the novel object recognition test and spatial delayed alternation test. On the other hand, the efficacy of the compound was not observed in the MK-801-induced hyperactivity test or prepulse inhibition. In summary, the observed antipsychotic activity profile of ALX-171 justifies the further development of the group of quinazolin-4-one derivatives in the search for a new drug candidate for schizophrenia treatment
Major liver resection results in early exacerbation of insulin resistance, and may be a risk factor of developing overt diabetes in the future
Rationally designed N-phenylsulfonylindoles as a tool for the analysis of the non-basic ligands binding mode
N-skatyltryptamines - dual 5-HT6R/D2R ligands with antipsychotic and procognitive potential
A series of N-skatyltryptamines was synthesized and their affinities for serotonin and dopamine receptors were determined. Compounds exhibited activity toward 5-HT(1A), 5-HT(2A), 5-HT(6), and D(2) receptors. Substitution patterns resulting in affinity/activity switches were identified and studied using homology modeling. Chosen hits were screened to determine their metabolism, permeability, hepatotoxicity, and CYP inhibition. Several D(2) receptor antagonists with additional 5-HT(6)R antagonist and agonist properties were identified. The former combination resembled known antipsychotic agents, while the latter was particularly interesting due to the fact that it has not been studied before. Selective 5-HT(6)R antagonists have been shown previously to produce procognitive and promnesic effects in several rodent models. Administration of 5-HT(6)R agonists was more ambiguous—in naive animals, it did not alter memory or produce slight amnesic effects, while in rodent models of memory impairment, they ameliorated the condition just like antagonists. Using the identified hit compounds 15 and 18, we tried to sort out the difference between ligands exhibiting the D(2)R antagonist function combined with 5-HT(6)R agonism, and mixed D(2)/5-HT(6)R antagonists in murine models of psychosis
Radiolabeling and in vivo evaluation of [<sup>11</sup>C]AGH-44:a potential lead structure to develop a positron emission tomography radioligand for the 5-HT<sub>7</sub> receptor
The effect of the intramolecular interactions on the conformational preferences of bis-arylsulfones – receptor antagonists and beyond
The development of compounds with enhanced activity and selectivity by a conserved spatial orientation of the pharmacophore elements has a long history in medicinal chemistry. Rigidified compounds are an example of this concept. However, the intramolecular interactions were seldom used as a basis for conformational restraints. Here, we show the weak intramolecular interactions that contribute to the relatively well-conserved geometry of N1-arylsulfonyl indole derivatives. The structure analysis along with quantum mechanics calculations revealed a crucial impact of the sulfonyl group on the compound geometry. The weak intramolecular C–H⋯O interaction stabilizes the mutual "facing" orientation of two aromatic fragments. These findings extend the pharmacological interpretation of the sulfonyl group role from the double hydrogen bond acceptor to the conformational scaffold based on intramolecular forces. This feature has, to date, been omitted in in silico drug discovery. Our results should increase the awareness of researchers to consider the conformational preference when designing new compounds or improving computational methods